Ranbaxy inaugurates manufacturing facility in Morocco

12 Mar 2012 Evaluate

Ranbaxy has opened its new manufacturing facility at Casablanca in Morocco, paving the way for a direct business pressure in North Africa. With the successful audit of the facility by the Moroccan Health Authorities, Ranbaxy Morocco is now authorized to commence manufacturing of its products at its Casablanca facility. The achievement of this milestone positions Ranbaxy will access a $1 billion pharmaceutical market in Morocco.

In addition to servicing the Morocco market, Ranbaxy also plans to extend the supply from this manufacturing unit to other African countries, in the coming years.

Ranbaxy has a strong presence in Africa. Following the addition of Morocco, the company now has three manufacturing facilities in Africa, the other two located in Nigeria and South Africa respectively. With five subsidiaries, five representative offices and a strong workforce of about 1000 people, Ranbaxy’s distribution network caters to 44 of the 54 countries in this continent.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×